Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8744195 | 0.80 | NAAA (0.44) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL8744192 | 0.80 | NAAA (0.44) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL11292223 | 0.80 | NAAA (0.44) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL28356061 | 0.79 | — | — | |
| SCHEMBL6103153 | 0.79 | — | — | |
| SCHEMBL16731037 | 0.79 | — | — | |
| SCHEMBL8744251 | 0.78 | TSHR (0.37) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL19999909 | 0.78 | MCL1 (0.35) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL8744248 | 0.78 | TSHR (0.37) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL1960559 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2542531-B1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2014-09-17 | — | — | EP | claimed |
| US-8507693-B2 | Process for synthesis of fipronil | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-08-13 | — | — | US | claimed |
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-01-31 | — | — | US | claimed |
| EP-2542531-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | Gharda, Keki Hormusji (IN) | 2013-01-09 | — | — | EP | claimed |
| WO-2011107998-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2011-09-09 | — | — | WO | claimed |
| EP-2542531-B1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2014-09-17 | — | — | EP | disclosed |
| US-8507693-B2 | Process for synthesis of fipronil | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-08-13 | — | — | US | disclosed |
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-01-31 | — | — | US | disclosed |
| EP-2542531-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | Gharda, Keki Hormusji (IN) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011107998-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | FIP1L1, CYP2F1, PFAS | NAAA 672/4885ALDH1A1 918/4885CYP1A2 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.